Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control by Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Powell Doherty, R, Marshall, JL, Cabrera Puig, I, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-labe... by Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Doherty, RP, Marshall, JL, Puig, IC, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM, TB042 Study Team